In middle-aged mice with alcohol-associated liver injury, dihydromyricetin and silybin produced distinct patterns of adaptation along the gut–liver axis rather than converging on a single hepatoprotective mechanism. The comparison indicates that two widely used plant-derived compounds act through separable routes involving intestinal and hepatic responses, which has implications for how such agents are selected in the context of age-related liver vulnerability.
Key Points
- Dihydromyricetin and silybin acted through separable gut–liver mechanisms
- Middle-aged mice modeled age-related vulnerability to alcohol-induced liver injury
- Hepatoprotective compounds are not mechanistically interchangeable
Longevity Analysis
The liver's capacity to clear and neutralize alcohol declines with age, and intestinal barrier integrity shapes how much inflammatory burden reaches hepatic tissue in the first place. Comparing two compounds that both carry hepatoprotective reputations but engage different points along this pathway argues against treating supplementation as a substitute for reducing the exposure itself. For practitioners, the more useful distinction is mechanistic: knowing whether an agent supports intestinal barrier function or hepatic processing determines whether it addresses the actual bottleneck in a given individual.
Original published by Nature - npj Aging, by Jiajun Lei.